[Rapporto di ricerca] Si prevede che il mercato dei vaccini per l'acquacoltura crescerà da 245,13 milioni di dollari nel 2021 a 569,72 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 12,9% dal 2022 al 2028.
Nelle pratiche di acquacoltura, esiste sempre la possibilità di focolai patogeni, che influiscono sulla produzione agricola. I vaccini per l’acquacoltura vengono utilizzati per proteggere i pesci da qualsiasi agente patogeno. La vaccinazione è una tecnica semplice, affidabile e preventiva per il controllo delle malattie nell'acquacoltura.
Approfondimenti di mercato
Il settore dell'acquacoltura in crescita guida la crescita del mercato
Secondo i dati in Secondo un rapporto intitolato “Lo stato della pesca e dell’acquacoltura mondiale” pubblicato dall’Organizzazione per l’alimentazione e l’agricoltura delle Nazioni Unite nel 2022, il consumo globale di alimenti acquatici, escluse le alghe, è aumentato di oltre cinque volte la quantità consumata quasi 60 anni fa. Il consumo di cibo acquatico in tutto il mondo è aumentato da 28 tonnellate nel 1961 a circa 158 tonnellate nel 2019. Il consumo è aumentato a un tasso medio annuo del 3,0% dal 1961, rispetto a un tasso di crescita della popolazione dell’1,6%. Il consumo pro capite è in aumento a causa dell’aumento dell’offerta, del cambiamento delle preferenze dei consumatori e dell’aumento del reddito. Nel 2019, l'Organizzazione delle Nazioni Unite per l'alimentazione e l'agricoltura ha stimato il consumo pro capite di alimenti acquatici in 227 paesi.
Per quanto riguarda la popolazione, i paesi che consumano meno della media mondiale rappresentano il 54% della popolazione mondiale nel 2019. Il consumo di alimenti acquatici è più elevato in Islanda, Isole Faroe e Maldive, che consumano oltre 80 kg di alimenti acquatici pro capite all’anno. Nel 2019 il consumo medio pro capite nel mondo è stato di 20,5 kg. Ciò differiva da una media di 5,4 kg nei paesi a basso reddito a 26,5 kg nei paesi ad alto reddito. Il crescente consumo di animali acquatici sta accelerando la crescita del settore dell’acquacoltura. I vaccini per l’acquacoltura riducono la possibilità di infezione e aumentano la resa dei prodotti. Pertanto, il crescente settore dell'acquacoltura alimenta la crescita del mercato dei vaccini per l'acquacoltura.
Approfondimenti strategici
L'aumento della prevalenza di malattie infettive negli animali acquatici offrirà ampie opportunità di mercato durante il periodo di previsione< /h3>
Secondo lo studio di ricerca intitolato "Prevalence of Anisakid Nematodes in Fish in China: A Systematic Review and Meta-Analysis" pubblicato dalla National Library of Medicine (NLM) nel febbraio 2022, i nematodi anisakidi erano diffusi in pesce in tutta la Cina con un tasso di incidenza complessivo del 45,5% e la percentuale di occorrenza per il pesce fresco è stata la maggiore (58,1%). La Cina orientale ha avuto il più alto tasso di prevalenza di nematodi anisakidi (55,3%), mentre la prevalenza di nematodi anisakidi (76,8%) è stata più alta nel Mar Cinese orientale. Secondo i dati pubblicati su Aquaculture Research & Development journal, dal 2014 al 2018 sono stati registrati ~219 casi di malattie infettive nel settore dell'acquacoltura fresca. Di questi, il 74,88% erano parassiti, il 12,80% batterici, l'1,83% virali e il 10,50% erano casi misti di parassiti e malattie batteriche. Pertanto, si prevede che l'elevata prevalenza di malattie infettive aumenterà la domanda di vaccini, il che fornirebbe opportunità redditizie per il mercato dei vaccini per l'acquacoltura nei prossimi anni.
Tipo di approfondimenti basati sui vaccini
< p> In base al tipo di vaccino, il mercato dei vaccini per l’acquacoltura è segmentato in vaccini vivi, vaccini inattivati e altri vaccini. Il segmento dei vaccini inattivati ha detenuto la quota di mercato maggiore nel 2021. È probabile che il mercato per il segmento dei vaccini vivi cresca al ritmo più elevato durante il periodo di previsione.Mercato dei vaccini per l'acquacoltura, per tipo di vaccino: 2021 e 2028
Approfondimenti basati sulle specie
Il mercato dei vaccini per l'acquacoltura, in base alle specie, è segmentato in tilapia, trota, salmone, gamberetti e altri. Il segmento del salmone ha rappresentato la quota maggiore del mercato nel 2021 e si prevede che registrerà il CAGR più elevato, pari al 13,4%, durante il periodo di previsione.
Percorso di approfondimenti basati sull'amministrazione
In base alla via di somministrazione, il mercato dei vaccini per l’acquacoltura è segmentato in iniezione, immersione e orale. Il segmento dell’iniezione ha rappresentato la quota maggiore del mercato nel 2021 e si prevede che registrerà il CAGR più elevato del 13,1% durante il periodo di previsione.
Le aziende adottano strategie inorganiche e organiche come fusioni e acquisizioni nel mercato dei vaccini per l'acquacoltura. Di seguito sono elencati alcuni recenti sviluppi chiave del mercato:
- Nel novembre 2022, Indian Immunologicals Ltd (IIL) ha collaborato con il Central Institute of Fisheries Education (CIFE) per lo sviluppo del primo pesce indiano vaccino in commercio. Il vaccino sarà sviluppato per la protezione dei pesci d'acqua dolce dalle comuni malattie batteriche.
- Nell'agosto 2021, Elanco Animal Health Incorporated ha acquisito Bayer Animal Health. La transazione, del valore di 6,89 miliardi di dollari, ha ampliato le dimensioni e le capacità di Elanco, posizionando l'azienda a lungo termine come leader nel settore della salute animale, attraente e durevole. La transazione ha aggiunto diversi marchi di bovini d'ancora, ha ampliato la presenza acquatica dell'azienda nei pesci d'acqua calda e ha migliorato il portafoglio globale di bioprotezione dell'azienda.
- Nel luglio 2020, Zoetis ha acquisito Fish Vet Group da Benchmark Holdings, PLC, come aggiunta strategica alla sua attività Pharmaq, che sviluppa e commercializza vaccini per pesci e offre servizi di vaccinazione e diagnostica per l'acquacoltura. L'acquisizione ha migliorato la portata geografica, le competenze diagnostiche e i servizi di analisi, compresi i test ambientali, che il laboratorio di riferimento di Pharmaq, Pharmaq Analytiq, può offrire agli acquacoltori nei principali mercati dell'acquacoltura.
Profili aziendali
- AquaTactics Fish Health
- HIPRA SA
- Merck & Co Inc
- Microsynbiotix Ltd
- Indian Immunologicals Ltd
- Nisseiken Co Ltd
- Zoetis Inc
- VETERQUIMICA SA< /li>
- Phibro Animal Health Corp
- Elanco Animal Health Inc
- Tecnovax SA
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The vaccine is used to establish or improve the immunity against a specific disease or group of diseases. In aquaculture practices, there is always a chance of pathogenic outbreaks, which will affect the production of the farm. Aquaculture vaccines are used to protect the fishes from any pathogen. Vaccination is a simple, reliable, and preventative technique of disease for aquaculture.
The factors driving the aquaculture vaccines market growth, includes growing aquaculture industry and the surging demand for aquatic animal-derived food products. However, strict regulatory policies for the approval of vaccines and the high cost of vaccines hinder the aquaculture vaccines market growth.
The aquaculture vaccines market majorly consists of the players, such as AquaTactics Fish Health, HIPRA SA, Merck & Co Inc, Microsynbiotix Ltd, Indian Immunologicals Ltd, Nisseiken Co Ltd, Zoetis Inc, VETERQUIMICA SA, Phibro Animal Health Corp, and Elanco Animal Health Inc.
The market is estimated to grow at a CAGR of 12.9% during the forecast period.
The aquaculture vaccines market was valued at US$ 245.13 million in 2021.
The aquaculture vaccines market is expected to be valued at US$ 569.72 million in 2028.
The aquaculture vaccines market, by type of vaccine, is segmented into live vaccines, inactivated vaccines, and other vaccines. The inactivated vaccines segment held the largest market share in 2021. However, live vaccines segment is anticipated to register the highest CAGR in the market during the forecast period.
The List of Companies - Aquaculture Vaccines Market
- AquaTactics Fish Health
- HIPRA SA
- Merck & Co Inc.
- Microsynbiotix Ltd
- Indian Immunologicals Ltd
- Nisseiken Co Ltd
- Zoetis Inc.
- VETERQUIMICA SA
- Phibro Animal Health Corp
- Elanco Animal Health Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Dec 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Dec 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Dec 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Dec 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)